The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Cancer therapy in the necroptosis era
Open accessAbstract
Necroptosis is a caspase-independent form of regulated cell death executed by the receptor-interacting protein kinase 1 (RIP1), RIP3, and mixed lineage kinase domain-like protein (MLKL). Recently, necroptosis-based cancer therapy has been proposed to be a novel strategy for antitumor treatment. However, a big controversy exists on whether this type of therapy is feasible or just a conceptual model. Proponents believe that because necroptosis and apoptosis use distinct molecular pathways, triggering necroptosis could be an alternative way to eradicate apoptosis-resistant cancer cells. This hypothesis has been preliminarily validated by recent studies. However, some skeptics doubt this strategy because of the intrinsic or acquired defects of necroptotic machinery observed in many cancer cells. Moreover, two other concerns are whether or not necroptosis inducers are selective in killing cancer cells without disturbing the normal cells and whether it will lead to inflammatory diseases. In this review, we summarize current studies surrounding this controversy on necroptosis-based antitumor research and discuss the advantages, potential issues, and countermeasures of this novel therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mantovani, A., Allavena, P., Sica, A., & Balkwill, F. (2008) · Nature · doi:10.1038/nature07205 · Cited by 11,399
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Targeting hypoxia in cancer therapy
Wilson, W. R., & Hay, M. P. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3064 · Cited by 3,172
Cho, Y., Challa, S., Moquin, D., Genga, R., Ray, T. D., Guildford, M., & Chan, F. K.-M. (2009) · Cell · doi:10.1016/j.cell.2009.05.037 · Cited by 2,435
Necroptosis and its role in inflammation
Pasparakis, M., & Vandenabeele, P. (2015) · Nature · doi:10.1038/nature14191 · Cited by 2,148
Identification of RIP1 kinase as a specific cellular target of necrostatins
Degterev, A., Hitomi, J., Germscheid, M., Ch'en, I. L., Korkina, O., Teng, X., Abbott, D., Cuny, G. D., Yuan, C., Wagner, G., et al. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.83 · Cited by 2,059
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis
Cai, Z., Jitkaew, S., Zhao, J., Chiang, H.-C., Choksi, S., Liu, J., Ward, Y., Wu, L.-G., & Liu, Z.-G. (2014) · Nature Cell Biology · doi:10.1038/ncb2883 · Cited by 1,322
Catalytic activity of the caspase-8–FLIPL complex inhibits RIPK3-dependent necrosis
Oberst, A., Dillon, C. P., Weinlich, R., McCormick, L. L., Fitzgerald, P., Pop, C., Hakem, R., Salvesen, G. S., & Green, D. R. (2011) · Nature · doi:10.1038/nature09852 · Cited by 1,278
RIP3 mediates the embryonic lethality of caspase-8-deficient mice
Kaiser, W. J., Upton, J. W., Long, A. B., Livingston-Rosanoff, D., Daley-Bauer, L. P., Hakem, R., Caspary, T., & Mocarski, E. S. (2011) · Nature · doi:10.1038/nature09857 · Cited by 1,057
Apoptosis, autophagy, necroptosis, and cancer metastasis
Su, Z., Yang, Z., Xu, Y., Chen, Y., & Yu, Q. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0321-5 · Cited by 1,042
Self-citationHitomi, J., Christofferson, D. E., Ng, A., Yao, J., Degterev, A., Xavier, R. J., & Yuan, J. (2008) · Cell · doi:10.1016/j.cell.2008.10.044 · Cited by 989
Wang, Z., Jiang, H., Chen, S., Du, F., & Wang, X. (2012) · Cell · doi:10.1016/j.cell.2011.11.030 · Cited by 949
The Catalogue of Somatic Mutations in Cancer (COSMIC)
Forbes, S. A., Bhamra, G., Bamford, S., Dawson, E., Kok, C., Clements, J., Menzies, A., Teague, J. W., Futreal, P. A., & Stratton, M. R. (2008) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg1011s57 · Cited by 904
Necroptosis as an alternative form of programmed cell death
Christofferson, D. E., & Yuan, J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.003 · Cited by 770
RIPK1 Blocks Early Postnatal Lethality Mediated by Caspase-8 and RIPK3
Dillon, C. P., Weinlich, R., Rodriguez, D. A., Cripps, J. G., Quarato, G., Gurung, P., Verbist, K. C., Brewer, T. L., Llambi, F., Gong, Y.-N., et al. (2014) · Cell · doi:10.1016/j.cell.2014.04.018 · Cited by 562
Radiation-induced apoptosis: Relevance to radiotherapy
Dewey, W. C., Ling, C. C., & Meyn, R. E. (1995) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)00214-8 · Cited by 523
Functional complementation between FADD and RIP1 in embryos and lymphocytes
Zhang, H., Zhou, X., McQuade, T., Li, J., Chan, F. K.-M., & Zhang, J. (2011) · Nature · doi:10.1038/nature09878 · Cited by 427
Necroptosis in health and diseases
Zhou, W., & Yuan, J. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.07.013 · Cited by 414
Shikonin circumvents cancer drug resistance by induction of a necroptotic death
Han, W., Li, L., Qiu, S., Lu, Q., Pan, Q., Gu, Y., Luo, J., & Hu, X. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0511 · Cited by 364
TRAIL induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation
Jouan-Lanhouet, S., Arshad, M. I., Piquet-Pellorce, C., Martin-Chouly, C., Le Moigne-Muller, G., Van Herreweghe, F., Takahashi, N., Sergent, O., Lagadic-Gossmann, D., Vandenabeele, P., et al. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.90 · Cited by 357
Vanlangenakker, N., Vanden Berghe, T., Bogaert, P., Laukens, B., Zobel, K., Deshayes, K., Vucic, D., Fulda, S., Vandenabeele, P., & Bertrand, M. J. M. (2011) · Cell Death & Differentiation · doi:10.1038/cdd.2010.138 · Cited by 339
Bonapace, L., Bornhauser, B. C., Schmitz, M., Cario, G., Ziegler, U., Niggli, F. K., Schäfer, B. W., Schrappe, M., Stanulla, M., & Bourquin, J.-P. (2010) · Journal of Clinical Investigation · doi:10.1172/jci39987 · Cited by 312
FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells
Bell, B. D., Leverrier, S., Weist, B. M., Newton, R. H., Arechiga, A. F., Luhrs, K. A., Morrissette, N. S., & Walsh, C. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808597105 · Cited by 295
RIP1/RIP3 Binding to HSV-1 ICP6 Initiates Necroptosis to Restrict Virus Propagation in Mice
Huang, Z., Wu, S.-Q., Liang, Y., Zhou, X., Chen, W., Li, L., Wu, J., Zhuang, Q., Chen, C., Li, J., et al. (2015) · Cell Host & Microbe · doi:10.1016/j.chom.2015.01.002 · Cited by 267
Saddoughi, S. A., Gencer, S., Peterson, Y. K., Ward, K. E., Mukhopadhyay, A., Oaks, J., Bielawski, J., Szulc, Z. M., Thomas, R. J., Selvam, S. P., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201283 · Cited by 264
Moriwaki, K., Bertin, J., Gough, P. J., Orlowski, G. M., & Chan, F. K. (2015) · Cell Death & Disease · doi:10.1038/cddis.2015.16 · Cited by 247
Basit, F., Cristofanon, S., & Fulda, S. (2013) · Cell Death & Differentiation · doi:10.1038/cdd.2013.45 · Cited by 211
Necroptosis, in vivo detection in experimental disease models
Jouan-Lanhouet, S., Riquet, F., Duprez, L., Vanden Berghe, T., Takahashi, N., & Vandenabeele, P. (2014) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2014.08.010 · Cited by 162
Genetic variation in 1253 immune and inflammation genes and risk of non-Hodgkin lymphoma
Cerhan, J. R., Ansell, S. M., Fredericksen, Z. S., Kay, N. E., Liebow, M., Call, T. G., Dogan, A., Cunningham, J. M., Wang, A. H., Liu-Mares, W., et al. (2007) · Blood · doi:10.1182/blood-2007-05-088682 · Cited by 161
Xie, X., Zhao, Y. C., Ma, C., Xu, X., Zhang, Y., Wang, C., Jin, J., Shen, X., Gao, J., Li, N., et al. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13184 · Cited by 159
Antigen-mediated T cell expansion regulated by parallel pathways of death
Ch’en, I. L., Beisner, D. R., Degterev, A., Lynch, C., Yuan, J., Hoffmann, A., & Hedrick, S. Μ. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808043105 · Cited by 143
Nugues, A.-L., Bouazzati, H. E., Hétuin, D., Berthon, C., Loyens, A., Bertrand, E., Jouy, N., Idziorek, T., & Quesnel, B. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.347 · Cited by 141
Colbert, L. E., Fisher, S. B., Hardy, C. W., Hall, W. A., Saka, B., Shelton, J. W., Petrova, A. V., Warren, M. D., Pantazides, B. G., Gandhi, K., et al. (2013) · Cancer · doi:10.1002/cncr.28144 · Cited by 133
He, W., Wang, Q., Srinivasan, B., Xu, J., Padilla, M. T., Li, Z., Wang, X., Liu, Y., Gou, X., Shen, H.-M., et al. (2014) · Oncogene · doi:10.1038/onc.2013.256 · Cited by 124 · cited 2×
“Nec-1 protection; ROS production; Hoechst/PI double staining Chalcone derivative chalcone-24 (Chal24) He et al.(57) Nec-1 protection; RIP1 and RIP3 knockdown OVCAR3 Human ovarian cancer cells IAPa (an IAP antagonist)+zVAD McCabe et al.”
BackgroundSteinhart, L., Belz, K., & Fulda, S. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.320 · Cited by 124
Xuan, Y., & Hu, X. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.09.029 · Cited by 123
Lu, J. V., Weist, B. M., van Raam, B. J., Marro, B. S., Nguyen, L. V., Srinivas, P., Bell, B. D., Luhrs, K. A., Lane, T. E., Salvesen, G. S., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102779108 · Cited by 122
Accumulation of Cytosolic Calcium Induces Necroptotic Cell Death in Human Neuroblastoma
Nomura, M., Ueno, A., Saga, K., Fukuzawa, M., & Kaneda, Y. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1283 · Cited by 119
Huang, C.-Y., Kuo, W.-T., Huang, Y.-C., Lee, T., & Yu, L. C. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.149 · Cited by 119
Schmidt, S. V., Seibert, S., Walch‐Rückheim, B., Vicinus, B., Kamionka, E.-M., Pahne‐Zeppenfeld, J., Solomayer, E., Kim, Y.-J., Bohle, R. M., & Smola, S. (2015) · Oncotarget · doi:10.18632/oncotarget.3249 · Cited by 116
Nehs, M. A., Lin, C., Kozono, D., Whang, E. E., Cho, N. L., Zhu, K., Moalem, J., Moore, F. D., & Ruan, D. T. (2011) · Surgery · doi:10.1016/j.surg.2011.09.012 · Cited by 114
Staurosporine Induces Necroptotic Cell Death under Caspase-Compromised Conditions in U937 Cells
Dunai, Z. A., Imre, G., Barna, G., Korcsmáros, T., Peták, I., Bauer, P. I., & Mihalik, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0041945 · Cited by 112
Liu, P., Xu, B., Shen, W., Zhu, H., Wu, W., Fu, Y., Chen, H., Dong, H., Zhu, Y., Miao, K., et al. (2011) · Leukemia · doi:10.1038/leu.2011.357 · Cited by 111
Metzig, M. O., Fuchs, D., Tagscherer, K. E., Gröne, H., Schirmacher, P., & Roth, W. (2015) · Oncogene · doi:10.1038/onc.2015.398 · Cited by 109
Laukens, B., Jennewein, C., Schenk, B., Vanlangenakker, N., Schier, A., Cristofanon, S., Zobel, K., Deshayes, K., Vucic, D., Jeremias, I., et al. (2011) · Neoplasia · doi:10.1593/neo.11610 · Cited by 107
Microarray analysis of promoter methylation in lung cancers
Fukasawa, M., Kimura, M., Morita, S., Matsubara, K., Yamanaka, S., Endo, C., Sakurada, A., Sato, M., Kondo, T., Horii, A., et al. (2006) · Journal of Human Genetics · doi:10.1007/s10038-005-0355-4 · Cited by 106
Necroptosis-Inducing Rhenium(V) Oxo Complexes
Suntharalingam, K., Awuah, S. G., Bruno, P. M., Johnstone, T. C., Wang, F., Wei, L., Zheng, Y., Page, J. E., Hemann, M. T., & Lippard, S. J. (2015) · Journal of the American Chemical Society · doi:10.1021/ja511978y · Cited by 98
Zhang, Q., Zhang, Y., Zhang, P., 晁振华, Xia, F., Jiang, C., Zhang, X., Jiang, Z., & Liu, H. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.9 · Cited by 97
Takemura, R., Takaki, H., Okada, S., Shime, H., Akazawa, T., Oshiumi, H., Matsumoto, M., Teshima, T., & Seya, T. (2015) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-14-0219 · Cited by 97
Yamanaka, K., Urano, Y., Takabe, W., Saito, Y., & Noguchi, N. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.524 · Cited by 96
TRAF2 inhibits TRAIL- and CD95L-induced apoptosis and necroptosis
Karl, I., Jossberger-Werner, M., Schmidt, N., Horn, S., Goebeler, M., Leverkus, M., Wajant, H., & Giner, T. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.404 · Cited by 93
5-ALA-PDT induces RIP3-dependent necrosis in glioblastoma
Coupienne, I., Fettweis, G., Rubio, N., Agostinis, P., & Piette, J. (2011) · Photochemical & Photobiological Sciences · doi:10.1039/c1pp05213f · Cited by 91
Chromik, J., Safferthal, C., Serve, H. L., & Fulda, S. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.10.018 · Cited by 87
Kim, S. K., Kim, W., Yoon, J.-H., Ji, J., Morgan, M. J., Cho, H., Kim, Y. C., & Kim, Y. (2015) · Journal of Investigative Dermatology · doi:10.1038/jid.2015.90 · Cited by 85
Yu, X., Deng, Q., Li, W., Xiao, L., Luo, X., Liu, X., Yang, L., Peng, S., Ding, Z., Feng, T., et al. (2014) · Oncotarget · doi:10.18632/oncotarget.3038 · Cited by 76
Meurette, O., Rébillard, A., Laurence Therese, H. U. C., Moigne, G. L., Mérino, D., Micheau, O., Lagadic‐Gossmann, D., & Dimanche‐Boitrel, M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1610 · Cited by 76
Wada, N. A., Kawano, Y., Fujiwara, S., Kikukawa, Y., Okuno, Y., Tasaki, M., Ueda, M., ANDO, Y., Yoshinaga, K., Ri, M., et al. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2804 · Cited by 75
Triggering necroptosis in cisplatin and IAP antagonist-resistant ovarian carcinoma
McCabe, K. E., Bacos, K., Lü, D., Delaney, J. R., Axelrod, J. L., Potter, M. D., Vamos, M., Wong, V., Cosford, N. D. P., Xiang, R., et al. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.448 · Cited by 67
A study of thermal dose-induced autophagy, apoptosis and necroptosis in colon cancer cells
Mouratidis, P., Rivens, I., & ter Haar, G. (2015) · International Journal of Hyperthermia · doi:10.3109/02656736.2015.1029995 · Cited by 60
Philipp, S., Sosna, J., Plenge, J., Kalthoff, H., & Adam, D. (2015) · Cell Communication and Signaling · doi:10.1186/s12964-015-0103-0 · Cited by 40
Ratovitski, E. A. (2015) · FEBS Letters · doi:10.1016/j.febslet.2015.04.020 · Cited by 21
Programmed Necrosis/Necroptosis: An Inflammatory Form of Cell Death
Chan, F. K.-M. (2013) · Springer eBooks · doi:10.1007/978-1-4614-9302-0_10 · Cited by 7
Cited by
Targeting Ferroptosis to Iron Out Cancer
Hassannia, B., Vandenabeele, P., & Vanden Berghe, T. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.04.002 · Cited by 2,478
The role of necroptosis in cancer biology and therapy
Gong, Y., Fan, Z., Luo, G., Yang, C., Huang, Q., Fan, K., Cheng, H., Jin, K., Ni, Q., Yu, X., et al. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1029-8 · Cited by 1,040
Regulated cell death (RCD) in cancer: key pathways and targeted therapies
Peng, F., Liao, M., Qin, R., Zhu, S., Peng, C., Fu, L., Chen, Y., & Han, B. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01110-y · Cited by 832
Self-citationPattern Recognition Receptors and the Host Cell Death Molecular Machinery
Amarante-Mendes, G. P., Adjemian, S., Branco, L. M., Zanetti, L. C., Weinlich, R., & Bortoluci, K. R. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02379 · Cited by 749
Tumor biomarkers for diagnosis, prognosis and targeted therapy
Zhou, Y., Tao, L., Qiu, J., Xu, J., Yang, X., Zhang, Y., Tian, X., Guan, X., Cen, X., & Zhao, Y. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01823-2 · Cited by 720
Metadata
- Authors
- Su, Z., Yang, Z., Xie, L., DeWitt, J. P., & Chen, Y.
- Venue
- Cell Death & Differentiation
- Published
- 2016-02-26
- Volume
- 23
- Issue
- 5
- Pages
- 748-756
- ISSN
- 1350-9047 (ISSN-L)
- 1476-5403
- OpenAlex
- W2283739034
- Cited by
- 333
- References
- 63
- FWCI
- 12.79
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.